SEC Form D · filed January 17, 2018
Syros Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (42)
Richard A. Young · Cambridge, MADirectorVicki Sato · Cambridge, MADirectorDavid A. Roth · Cambridge, MAExecSrinivas Akkaraju · Cambridge, MADirectorRobert Nelsen · Cambridge, MADirectorSanj A. Patel · Cambridge, MADirectorJeremy A. Springhorn · Cambridge, MAExecNancy Simonian · Cambridge, MAExec · DirectorGerald A. Quirk · Cambridge, MAExecEric A. Olson · Cambridge, MAExecPhilip Sharp · Cambridge, MADirectorMarsha A. Fanucci · Cambridge, MADirectorAmir Nashat · Cambridge, MADirectorPeter Wirth · Cambridge, MADirectorBen Blume · San Francisco, CADirectorRobert F. Jacobs · Rowayton, CTExecJohn Chaffetz · Seattle, WAExecTeddie Wardi · San Francisco, CADirectorMarc C. Ganzi · Boca Raton, FLDirectorWilliam F. Doyle · New York, NYDirectorBrad J. Rummer · Dallas, TXDirectorDaniel Perez · San Francisco, CADirectorDavid E. Smith · Phoenix, AZDirectorRichard J. Deslauriers · Woodbury, CTExecStephanie Sanborn · Playa Vista, CAExec · DirectorAnthony Ardizzone · Phoenix, AZDirectorGabriel Mecklenburg · San Francisco, CADirectorDavid Enslow · Seattle, WAExecJoseph Patt · New York, NYDirectorKevin Prociw · Phoenix, AZDirectorLance Larsen · Port Chester, NYDirectorRyan Larsen · Salt Lake City, UTDirectorRaz Winiarsky · Hackensack, NJDirectorClayton Wood · SEATTLE, WAExecYongbai Choi · SEATTLE, WAExecMark V. Richards · Harlingen, TXDirectorWilliam L. Elliff · Harlingen, TXExecMichael F. Scaief · Harlingen, TXDirectorRobert R. Farris · Harlingen, TXExecTudor G. Uhlhorn · Harlingen, TXDirectorCarlos L. Varela · Harlingen, TXExec · DirectorAndrew Weatherford · Tampa, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗